H. Zetterberg

发表

Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's disease.

K. Blennow, A. Labonté, C. Picard, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI

K. Blennow, A. Håberg, T. Skandsen, 2024, Journal of neuroinflammation.

Biomarker Discovery in Alzheimer's and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich Assay

K. Blennow, L. Montoliu-Gaya, N. Ashton, 2024, medRxiv.

Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting

K. Blennow, W. Klunk, D. Tudorascu, 2024, Molecular neurodegeneration.

Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings

K. Blennow, L. Montoliu-Gaya, A. Orellana, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals

K. Blennow, S. Sandberg, A. Jeromin, 2023, medRxiv.

Widespread white matter abnormalities in concussed athletes detected by 7T diffusion MRI.

K. Blennow, E. Kornaropoulos, Y. Tegner, 2024, Journal of neurotrauma.

Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects

K. Blennow, Yi Li, Patrick Harvey, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Tau protein profiling in tauopathies: a human brain study

Björn M. Burmann, K. Blennow, J. Gobom, 2024, Molecular neurodegeneration.

Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer

Toshima Z. Parris, A. Abramsson, K. Helou, 2024, Cell death discovery.

CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease.

K. Blennow, N. Seyfried, A. Mecca, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease

Young Ho Park, Jung-Min Pyun, K. Shim, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Spatial Neurolipidomics at the Single Amyloid-β Plaque Level in Postmortem Human Alzheimer’s Disease Brain

K. Blennow, T. Lashley, Junyue Ge, 2024, ACS chemical neuroscience.

Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.

K. Blennow, M. Alosco, G. Babulal, 2024, Journal of Alzheimer's disease : JAD.

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

K. Blennow, S. Janelidze, S. Palmqvist, 2024, Molecular neurodegeneration.

Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA

K. Blennow, A. Benussi, N. Ashton, 2024, Neurobiology of Aging.

Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

K. Blennow, J. Soucy, P. Rosa-Neto, 2024, Molecular neurodegeneration.

Plasma P-Tau181 and Amyloid Markers in Alzheimer's Disease: A Method Comparison between Simoa and Lumipulse

K. Blennow, A. Benussi, N. Ashton, 2024, SSRN Electronic Journal.

CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease.

K. Blennow, E. Arenaza-Urquijo, G. Sánchez-Benavides, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Microstructural associations between locus coeruleus, cortical, and subcortical regions are modulated by astrocyte reactivity: a 7T MRI adult lifespan study

K. Blennow, N. Ashton, Maxime Van Egroo, 2024, Cerebral cortex.

Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.

K. Blennow, P. Sánchez-Juan, E. Rodríguez-Rodríguez, 2024, Journal of Alzheimer's disease : JAD.

Spatial neurolipidomics-MALDI mass spectrometry imaging of lipids in brain pathologies.

K. Blennow, Jörg Hanrieder, Durga Jha, 2024, Journal of mass spectrometry : JMS.

Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET

K. Blennow, S. Helin, Elina Pietilä, 2024, Neurobiology of Disease.

Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease

K. Blennow, B. Mroczko, M. Dulewicz, 2024, International journal of molecular sciences.

Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients

K. Blennow, F. Ribaldi, N. Ashton, 2024, Alzheimer's research & therapy.